Cor Vasa 2023, 65(2):186-235 | DOI: 10.33678/cor.2023.023

(2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.)

Petr Peichl^a, Alan Bulava^b, Ondřej Toman^c, Josef Kautzner^a

^a Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

^b Kardiocentrum, Nemocnice České Budějovice, a. s., a Zdravotně sociální fakulta Jihočeské univerzity v Českých Budějovicích, České Budějovice

^c Interní kardiologická klinika, Fakultní nemocnice Brno, Brno

(Translation of the shortened document prepared by the Czech Society of Cardiology)
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group.

Keywords: anti-arrhythmic drugs, cardiac magnetic resonance, cardiomyopathies, catheter ablation, chronic coronary artery disease, genetic testing, implantable cardioverter defibrillator, premature ventricular complex, primary electrical disease, risk calculator, risk stratification, sudden cardiac death, sudden death, ventricular arrhythmia, ventricular tachycardia,

Received: March 19, 2023; Accepted: March 20, 2023; Published: May 1, 2023  Show citation